Via Surgical Ltd., Closes $6M Investment Led by Benslie Investment Group

MIRIM, IsraelFebruary 8, 2016 /PRNewswire/ —

Via Surgical Ltd., a leading developer of novel surgical fixation technologies for mesh placement in hernia repair, announced today the company has secured a $6M investment led by Benslie investment group.

Nicolas Weinstein, managing partner at Benslie will join the Via Surgical Board of Directors.

Lena Levin, the Company’s Co-founder and CFO, notes: “The addition of Benslie Investment group to our highly experienced team validates the opportunity to advance patient care with the FasTouch™ Deployable Suture Fixation System. Their investment will greatly support the increasing clinical demand for improved fixation through our development and commercialization efforts in 2016.

FasTouch™, a novel fixation technology is the first with the potential to provide a comprehensive fixation solution in hernia repair.  The lockable sutures are designed to signficantly minimize foreign body material, providing the first and only light-weight hernia fixation system.”

“We are very excited to partner with Via Surgical to introduce a novel hernia mesh fastening device with the potential to improve patient outcomes. It is a fantastic device that benefits all stakeholders. Via Surgical is a great addition to our portfolio of healthcare companies with a proven team, top advisory board and late stage technology” observed Nicolas Weinstein managing partner at Benslie.

About Via Surgical Ltd.

Via Surgical Ltd. provides next-generation fixation technology. Realizing that many hernia repairs make use of multiple means for mesh fixation – anchor/helical hernia tacks, manually applied transfascial sutures – Via Surgical has developed its FasTouch™ system to provide deployable suture fixation that is strong and consistent, yet easily and rapidly deployed for hernia repair.

Please visit https://www.viasurgical.com for more information.

About Benslie

Benslie investment group is led by Mr. Alejandro Weinstein Manieu.  Mr. Weinstein carries extensive industry experience. He transformed a local Chilean pharmaceutical company, CFR Pharmaceuticals, into a global pharmaceutical powerhouse, eventually selling it in 2014.  Mr. Weinstein has served as a board member for various pharmaceutical companies in Latin AmericaEurope, and South East Asia, and of several social initiatives such as Educa UC, Fundación Genomika, and Consorcio Tecnologico en Biomedicina.

Contact:
Ofek Levin
Co-Founder and CEO
info@viasurgical.com
+972-52-63-95-765

Schedule a demo

Click below to schedule a demo or have a sales rep contact you

× Password Empty or Invalid.

Please try again!!